GTHX — G1 Therapeutics Share News
0.000.00%
Last trade - 00:00- $377.22m
- $360.81m
- $82.51m
G1 Therapeutics Inc expected to post a loss of 84 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP- Arista Networks, Dominion Energy, TransDigm Group
U.S. STOCKS ON THE MOVE-Ralph Lauren, Howmet, Insulet
U.S. STOCKS ON THE MOVE-Top Ships, Brightcove, Airbnb
G1 Therapeutics hits record low on plans to scrap drug study in colon cancer
U.S. STOCKS ON THE MOVE-Ocular Therapeutix, Microsoft, Novavax
U.S. STOCKS ON THE MOVE-Meta, Bed Bath & Beyond
G1 Therapeutics falls on plans to discontinue cancer drug study
G1 Therapeutics to discontinue cancer drug trial, shares plunge 40% (updated)
G1 Therapeutics to discontinue cancer drug trial
Brief: Simcere Pharmaceutical Announce Issuance Of First Prescription For COSELA(Trilaciclib) In China
Brief: G1 Therapeutics Provides Initial Update On Phase 2 Bladder Cancer
Brief: G1 Therapeutics Says Initial Results From Phase 2 Mechanism Of Action Trial In Breast Cancer Show That Single Dose Of Trilaciclib Favorably Alters The Tumor Microenvironment
Brief: G1 Therapeutics Announces Closing Of Offering Of Common Stock
U.S. STOCKS ON THE MOVE-Grindr, Utilities, StoneCo, Carvana
U.S. STOCKS ON THE MOVE-Foot Locker, Applied Materials, Iveric
U.S. STOCKS ON THE MOVE-JD.com, Gap, Ross Stores
G1 Therapeutics tumbles on pricing $50 mln stock offering
Brief: G1 Therapeutics Announces Pricing Of Offering Of Common Stock